Continuous Glucose Monitoring can be used to diagnose gestational diabetes

Using continuous glucose monitoring to diagnose pregnant women with gestational diabetes is more effective than the standard oral glucose tolerance test, research has demonstrated.

A team of academics assessed the acceptability, feasibility, and accuracy of continuous glucose monitoring (CGM) as a diagnostic test for gestational diabetes.

During the study, the researchers examined the health outcomes of 73 pregnant women who completed CGM for a week and 34 expecting mothers who concurrently underwent an oral glucose tolerance test.

They found that CGM was acceptable and generally well-tolerated, with skin irritation and itchiness the only adverse event.

The findings have stated: “An oral glucose tolerance test is dated and has been reported as inconvenient for women as well as poorly reproducible and reliable.”

Future research is needed to determine cut-off values for CGM-defined and oral glucose tolerance test-independent screening criteria for gestational diabetes.

To read the study, click here.